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Te Mata Ira: Guidelines  
for Genomic Research  
with Māori
Me ātahaere mā ngā ngaru,  
kei tōtohu i te aroha o Tangaroa
Introduction
Māori ethical frameworks recognise that all research in New Zealand is of  
interest to Māori and outline community expectations of appropriate behavior  
in research to deliver the best outcomes for Māori. Research contributes to the  
broader development objectives of society. Ethics has a specific role in guiding  
key behaviours, processes and methodologies used in research. 
This document outlines a framework for addressing Māori ethical issues within  
the context of genetic or genomic research. It draws on a foundation of mātauranga 
(Māori knowledge) and tikanga Māori (Māori protocols and practices) and will 
be useful for researchers, ethics committee members and those who engage 
in consultation or advice about genomic research with Māori in local, regional, 
national or international settings.
Genomic Research 
Genomic research represents a new frontier for health research, providing 
the platform for the introduction of personalised or precision medicine and 
pharmacogenomics. 
While genetic research looks at the function of specific genes, genomic research 
looks at the functions of groups of genes and their interactions with the 
environment. 
Technology is constantly evolving and next generation ‘omics’ research including 
proteomics, metabolomics, transcriptomics, and epigenetics is becoming part  
of the health research environment. While this guidelines focus on genomic 
research they will be relevant to these new types of biomedical research.
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Te Ara Tika
Te Ara Tika Guidelines for Māori Research Ethics: A framework for Researchers and 
Ethics Committee Members (Hudson et al, 2010) brought together various strands 
connecting tikanga Māori, the principles of the Treaty of Waitangi, Māori research 
ethics, and the health research context in a way that could be understood and applied 
in a practical manner by researchers and ethics committees (Hudson et al., 2016). 
The purpose of the Te Ara Tika guidelines was to explain key ethical concepts for 
Māori; to support decision-making around Māori ethical issues; to identify ways to 
address Māori ethical concerns; and to clarify the roles of Māori ethics committee 
members. 
The Māori ethics framework within Te Ara Tika references four tikanga based 
principles whakapapa (relationships), tika (research design), manaakitanga (cultural 
and social responsibility), and mana (justice and equity) as the primary ethical 
principles in relation to research ethics. Te Ara Tika provides the framework for 
researchers to engage with Māori communities and issues that are important to them. 
Figure 1:  
Māori Ethical  
Framework
Mainstream 
 
 
                         Cultural Sensitivity  
 
 
 
  
 
     
     
     
    
    
    
    
    
    
    
 M
an
a 
Ta
ng
at
a
 Māori-centred 
 
         Cultural Safety 
 
 
  
      
   M
an
a 
w
he
nu
a
     
    
  W
ha
ka
ha
er
e 
     
      
       K
aupapa
Engagement
Consultation
      
        M
āori  
      M
āhaki 
 
                  
      
     
    
    
 M
an
a
Kaitiaki
Pa
rtn
er
sh
ip 
     
    P
ar
tic
ipa
tio
n  
     
    P
ro
tec
tio
n
Whakapono               Tūmanko                      Aroha
     
     
    R
isk
s   
     
     
     
     
   B
en
efi
ts 
     
     
     
    O
utc
om
es
             Rights                          Roles                    Responsibilities
M
A
N
A 
Ju
st
ic
e 
an
d 
Eq
ui
ty
   
   
    
    
    
    
    
    
    
    
    
     
     
     
      
      
       
         
     TIKA
 Research Design                                                          M
ANAAK
ITA
N
GA Cultural &
 Social Responsibility
WHAKAPAPA Relationshi
ps
Te Ara Tika also identified a range of areas that required special ethical consideration 
including the collection and use of human tissue, genetic research, ongoing storage 
in tissue banks, the establishment of cell lines, tissue being sent overseas, and future 
unspecified use. 
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Te Mata Ira
Given the increasing prevalence of genomic research, creation of research biobanks, 
and the international nature of research collaborations, it was timely that the Health 
Research Council funded the Te Mata Ira research project to explore Māori views on 
genomic research and biobanking. 
General Māori objections to genetic research1 are tempered in the context of health 
research when there is direct benefit to Māori whānau2. While not all whānau or Iwi 
will agree to participate in genomic research there are an increasing number that 
are choosing to engage with genomic researchers. One of the aims of the Te Mata Ira 
project was to identify ways to protect the interests of Māori participants and groups 
that choose to participate in genetic or genomic research.
Te Mata Ira translates to ‘the different faces of a gene’ and acknowledges that Iwi or 
Māori groups would have different ways of understanding or relating to genetic and 
genomic research. The project sought input from Māori across a diverse range of 
settings including whānau, hapū, Iwi, Māori health workers, Māori researchers,  
social scientists, biomedical scientists, and Indigenous researchers3. It also engaged 
with non-Māori scientists, researchers and biobank managers and administrators  
to both gauge what they understood about Māori concerns and assist with identifying 
potential solutions.
The project identified key themes relevant to genomic research for Māori, and for Iwi4.
Māori Iwi
Protection of Māori rights and interests Tissue removed for a range of reasons (clinical and research)
Focus on Māori health priorities Whānau make decisions, hapū and Iwi support interests
Robustness of genomic research methods Experience loss of control (over time)
Control over samples and data Accountability of research organisations
Expectations of consultation Iwi governance over projects is expected
Expectations of consent Communication about progress and results is essential
Ongoing feedback and communication Outcomes for participants, Iwi and communities
Education is important
Table 1: Key Themes Relevant To Genomic Research
1 Cram (2005), Hook (2009), Rochford (2011).
2 Durie (2008), Du Plessis et al. (2004), Roberts & Fairweather (2005), Tipene-Matua (2006),  
Tipene-Matua & Wakefield (2007), Tupara (2012).
3 The information collected through the Te Mata Ira research project informs the content of these 
guidelines.
4 Iwi that provided input to the Te Mata Ira project included Ngāti Hine, Ngāti Porou, Ngāti 
Rakaipaaka, Southern Runaka o Ngāi Tahu, and Ngāti Whatua ki Ōrakei.
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Purpose
The purpose of the Te Mata Ira Guidelines for Genomic Research with Māori is  
to describe the cultural foundation informing ethical approaches to genomics;  
to inform decision-making around ethical issues when conducting genomic 
research with Māori; and outline best practice approaches for addressing Māori  
ethical concerns.
The Te Mata Ira Guidelines on Genomic Research with Māori are designed to be 
read in conjunction with Te Ara Tika Guidelines for Māori Research Ethics. Te Ara 
Tika provides generic advice for all health research and the Te Mata Ira guidelines 
provides more specific guidance for the context of genomic research (and other 
‘omics’ related biomedical research).
Background to the Guidelines and the Framework
The Te Mata Ira Framework is designed to build on the guidance provided by Te Ara 
Tika because the Māori ethical issues identified in that document are relevant to all 
research, including genomic research. The Te Mata Ira framework aligns with the 
key principles of Te Ara Tika and considers their application to genomic research 
from consultation to research and post-project transformation. These stages within 
the research process provide distinct opportunities to engage Māori communities 
in specific discussions about the research project and the results. 
Te Ara Tika
Whakapapa Mana Tika Manaakitanga
Consultation
Kawa Governance Purpose Benefit
Research
Tikanga Consent Methods Communication
Transformation
Accountability Kaitiaki Translation Education
 
Figure 2: Te Mata Ira Framework for Genomic Research with Māori
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Within Te Ara Tika, whakapapa (genealogy) refers to the nature of relationships 
between the researchers, communities and participants. Kawa (principles) 
and Tikanga (protocols) provide a framework for cultural engagement and 
contribute to the levels of accountability. The recognition of Mana (power, control) 
supports the realisation of justice and equity. The mana of participants and 
their communities can be enhanced through the use of community governance 
and consent mechanisms, and involvement of kaitiaki (guardians). Tika (right, 
correct) is associated with the research design and this can be considered in 
relation to the purpose, methodology and translational components of a research 
project. Manaakitanga (to look after, care for) represents the cultural and social 
responsibility where the benefits, communication and education are key pathways 
to realising community outcomes.
Te Mata Ira: Guidelines for Genomic Research with Māori6
Section 1
Cultural Foundation
Cultural worldviews are embedded with a logic that prioritises specific values  
and shape appropriate ethical behaviour. Māori ground their thinking about 
genomic research and biobanking in a Māori worldview through a range of 
culturally significant reference points reinforced through kawa and tikanga. 
Ethics is about values, and ethical behaviour reflects values held by people at large. 
For Māori, ethics is about ‘tikanga’– for tikanga reflects our values, our beliefs and 
the way we view the world.
Māori recognise that genomic research is an on-going endeavor and that a range 
of decisions need to be made throughout the period of the project. Māori reiterated 
the importance of identifying and acknowledging cultural values and concepts, and 
engaging with the community in the development of appropriate ethical boundaries 
for genomic projects. 
The cultural foundation outlines key cultural concepts that inform Māori 
understandings of genetics and how they apply to the context of genomic research. 
The descriptions will also support initiatives to improve genetic literacy within 
Māori communities. 
Figure 3: Key Cultural  
Values/Concepts Relevant  
to Genomic Research
Whakapapa
Taonga
Tikanga
Tapu
Tākoha
KawaMauri
Wairua
Mana
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A whakataukī was created by two kaumātua5 that participated in the Te Mata Ira 
project. The whakataukī uses the metaphor of a wave to represent the challenge 
for Iwi and researchers when engaging with genomic research with Māori 
communities. Whether you are riding on the wave or facing an on-coming wave  
you should tread carefully to safely negotiate the event. 
Me ātahaere mā ngā ngaru, kei tōtohu  
i te aroha o Tangaroa 
Tread carefully in challenging waters
Protecting Whakapapa
Whakapapa is a key reference point for Māori when talking about health and 
genetics. Whakapapa was described as the connection between people and 
creates a responsibility for both future and past generations. Whakapapa is often 
used as a framework to describe a range of connections including genealogy, 
social and ecological relationships, cultural histories, family traits, and ancestral 
inheritances. At a physical and spiritual level, whakapapa is embodied within the 
DNA of a person and therefore the storage and use of human tissue for genetic/
genomic research becomes a culturally significant activity. When individuals 
consent to participate in genomic research, the biological material and personal 
information they contribute is a key part of the research endeavor, which Māori 
consider to be culturally significant. As such, a core responsibility for whānau,  
hapū and Iwi is to ensure that whakapapa is protected, in part, by managing the 
access and use of information relevant to whakapapa. The protection of whakapapa 
is a key consideration for Māori especially when engaging in genomic research
Whakapapa is used to explain both the genesis and purpose of any particular 
kaupapa (topic/purpose). Whakapapa is an analytical tool for not only 
understanding why relationships have been formed but also monitoring how the 
relationships progress and develop over time (mai i te whai ao ki te ao mārama). 
Within the context of decision-making about ethics, whakapapa refers to quality 
of relationships and the structures or processes that have been established to 
support these relationships. In research, the development and maintenance of 
meaningful relationships between researcher and research participant forms 
another axis of consideration for evaluating the ethical tenor of a research  
project and its associated activity.
5 Huata Holmes, Kai Tahu and Moe Milne, Ngati Hine.
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Figure 4: Aspects of Whakapapa
He Taonga, He Tapu
The concept of taonga refers to something precious or significant. The term taonga 
can be applied to valued objects, significant resources, or important entities. 
Taonga should be looked after in an appropriate manner to preserve their integrity 
and value as well as respect the tapu that has been imbued into them. Tapu refers 
to the sacred or special nature of an object and implies that the object must be 
actively protected or managed. 
Human tissue is considered a taonga and DNA from any genetic origin that 
connects to whakapapa is also considered a taonga. Iwi recognise the value of DNA 
for its cultural and spiritual significance as well as its usefulness as a resource for 
research. Genomic data, as a representation of peoples’ biological material, is also 
considered a taonga and a highly valuable strategic asset for Māori. 
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Figure 5: Components  
of Human Tissue that  
are Considered Taonga
Taonga
DNA
DataTissue
Tākoha
Koha is often conceptualised as a gift. Tākoha is a form of gifting that recognises 
the tapu associated with a gift and indicates that conditions are to be applied to the 
taonga being gifted. Tissue consented for use in genomic research is considered  
a gift or donation however when applying the concept of tākoha the gift refers  
to the ‘responsibility’ to look after the tissue.
Kawa for Genomic Research
Kawa and tikanga provide the primary interface for accessing repositories of 
cultural knowledge and experience that can be used to inform ethical deliberations. 
Kawa refers to the core values and ethical principles that underpin a Māori 
worldview. The creation of kawa to inform genomic research provides researchers 
with a set of statements to inform the decisions they make once they have been 
gifted the responsibility to look after Māori tissue and DNA. The kawa have a dual 
function in that they represent both ethical principles that can inform decision-
making as well as desired outcomes for the participants and communities. 
I. Kia tau te wairua o te tangata
Wairua is a core philosophical concept that pervades all aspects of Māori society 
and is a central element of cultural protocols. It refers to the spiritual dimension 
and within Māori models of health it is a key component of a person’s wellbeing 
(Durie 2005, Ahuriri-Driscoll et al., 2012). Wairua is a concept to consciously 
address as it could both influence relationships and outcomes of genomic research 
as well as be impacted by them. An injury to a person’s wairua negatively affects 
their wellbeing so ensuring whānau are comfortable with their involvement in 
genomic research is of importance here.
‘Kia tau te wairua o te tangata’ refers to the ‘level of comfort’ that participants  
and communities have in the research project. 
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The level of comfort changes over time so a variety of different actions contribute 
to achieving this outcome. These actions might include engagement with Iwi, use 
of cultural protocols during consenting process, encouraging whānau support, 
communicating research results, transparent governance, and accessible 
researchers.
TAHA WHA-NAU 
Extended family health 
Wider social systems; 
belonging, sharing  
and caring
TAHA WAIRUA 
Spiritual health 
Unseen and unspoken 
energies; faith and 
spirtual awareness
TAHA HINENGARO 
Mental health 
Inseparability of mind 
and body; expressing 
thoughts and feelings
TAHA TINANA 
Physical health 
Good physical health
Figure 6: Te Whare Tapa Wha – Māori Model of Health and Wellbeing
Examples
He Kamaka Waiora at the Waitemata and Auckland DHB’s provides cultural support 
to patients and staff across the hospital services through kaumatua and kaimanaaki 
roles. An example was given where the Chief Advisor Tikanga was asked to support 
a Māori patient that had received a new lung in a transplant procedure. The patient 
was not doing well post-operatively and the Chief Advisor Tikanga asked whether the 
whānau had conducted any ceremonies to farewell the old heart and welcome the new 
one into the patients body. The whānau agreed that this would be appropriate and once 
completed the patient made a speedy recovery. 
Dr Melanie Cheung led work at the Neurological Foundation Human Brain Bank to 
look at how core Māori values can guide the process of working with human tissue. 
One of the cutting edge methods used on tissues samples in the laboratory involves 
growing cells from post-mortem and post-operative brain tissue. The development 
of appropriate tikanga for the laboratory supports culturally safe practice for both 
researchers and whānau. The process of seeking guidance of kaumātua, kuia, whānau, 
hapū, and iwi resulted in the use of specific karakia, waiata, kai and wai to whakanoa 
samples as they enter the laboratory environment.6
6 Cheung, M. J. (2011). Cellular and Cultural Studies of Human Neurodegenerative diseases.  
(PhD Thesis, University of Auckland).
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II. Kia pumau te mana o te tangata
Mana commonly refers to power, control or prestige. Different types of mana 
(mana atua, mana whenua, mana tangata) describe different levels of control 
and responsibility for decision-making. There are recognised rights for Māori 
collectives (whānau, hapū or Iwi) to engage with researchers in consultation  
around the appropriateness of a genomic research study for their community. 
Whānau have rights to choose whether they engage in genomic research and/or 
provide samples for genomic research and expect that hapū/Iwi will support them 
as required in the context of that relationship. Iwi assistance may also be necessary 
to ensure whānau can access research information, access services,  
or provide cultural support as whānau make difficult decisions. To address the 
power imbalance inherit in the participant-researcher relationship, community 
members see hapū and Iwi entities using their mana whenua status to support  
and protect their interests. 
‘Kia pumau te mana o te tangata’ refers to the ‘level of control’ that participants  
and communities have in relation to the research project. 
The level of control that communities and participants have in the context  
of their relationship with the research team changes over the course of a project. 
Their level of influence tends to be greater during the consultation (in the case  
of communities) and consent (in the case of participants) phases of the project,  
and reduces over time. Efforts should be made to engage and empower 
participants and communities of interest through out the life of the project  
to achieve this outcome. 
Examples
The University of Otago and a North Island Māori stomach cancer kindred (represented 
by the Kimihauora Research Unit and a Trust) entered into two agreements,  
a patent joint venture agreement and a research agreement. The research agreement 
specified that the research was a joint venture, outlined the roles of the two parties 
in the research and noted that all biological samples and information related to 
the whakapapa remained the property of the whānau. It further specified that the 
University researchers must provide quarterly progress reports to Kimihauora. 
The patent agreement specified that a management committee be established to 
oversee any commercialisation process. The committee would comprise two whānau 
representatives and two University representatives. Patent rights would be held equally 
between the two parties. The University agreed to meet patenting costs alone, on the 
condition that they would be recovered should there be any future revenue flow.
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Dr Merriman, Department of Biochemistry, University of Otago (UoO) presented a paper 
in July 2012 to the Ngati Porou Hauora Charitable Trust (NPHCT) Board regarding 
a proposed variation to data analysis plans for the ‘Genetics of Gout in Tairawhiti’ 
project (begun 2007) and which would also be applicable to the ‘Genetics of Gout and 
Co-morbidities: genes and environment’ project (begun 2013). Approval was sought 
such “that the whole genome provided by the NPH gout research participants to date 
is determined and stored as computer-data (rather than DNA in solution) in the secure 
IT systems of the Biochemistry Department at the University of Otago”. The Board 
responded with one condition being that ‘An agreement is signed between the Ngati 
Porou Hauora Charitable Trust and the University of Otago that provides a framework 
for the use, storage, and protection, of whole genome sequence data from participants 
in the two gout genetics projects’.
III. Kia hiki te mauri o te kaupapa
Mauri is a core concept underpinning the Māori worldview. It can be described as 
the ‘life essence’ and is applied to both animate and inanimate objects. Maintaining 
the mauri can be thought of as maintaining the genetic or biological integrity of an 
organism or system. Ensuring that mauri is maintained or enhanced improves the 
level of public trust and accountability between genomic researchers and Māori 
communities.
‘Kia hiki te mauri o te kaupapa’ refers to the ‘level of integrity’ present within  
the systems that contribute to the research endeavour.
The level of integrity in the systems that support research and the transformation 
of services (research organisations, ethics committees, funding bodies, health 
system) is integral to the level of support and trust that Māori communities have  
in research. Researchers have a responsibility to build an understanding of 
genomics and develop trust with Māori communities through their activities and 
actions. Greater levels of transparency and communication about their research 
projects will contribute to the realisation of this outcome. 
Examples
Recent changes in the process of ethical review for Health and Disability research 
led the Māori Research Review Committees to develop a framework for Māori review 
of research in DHB’s. Standardisation has several potential advantages including 
increased efficiency of time, energy and resource, as well as improved national 
consistency while still allowing for consideration of local context and collaboration with 
manawhenua. The framework makes an important contribution to ensuring the rights 
of Māori are upheld in the research setting (Simmonds, 2015).
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The NETwork! project is a collaborative research group working with communities, 
clinicians and researchers to advance understanding and treatments for Neuro-
Endocrine Tumours. It has developed a dedicated website7 which it uses to better 
communicate with research partners around New Zealand, and keep them up to date 
with the overall progress of the project. As part of the development of this website, 
the decision was made to provide a Māori translation in order to make the information 
about the NETwork! project more accessible. We hope that this will facilitate informed 
participation by Māori patients and their whānau. Māori participation is essential to 
the getting a clearer picture of Neuroendocrine Cancer in NZ, and facilitating the 
development of a suitable multidisciplinary framework that will ensure benefits from 
the study flow on to all New Zealanders. The Te Reo translations were provided by  
Dr David Jansen, who helped with the intricate task of translating some of the 
technical explanations of our project. David is Ngāti Raukawa and a qualified medical 
practitioner. His main focus is on running clinical teaching and Te Reo programmes 
throughout New Zealand and in 2006 he produced a phrase book of Māori  
medical terms.
Tikanga for Genomic Research
Tikanga refers to the specific protocols or processes that people follow to ensure 
that their values and principles are maintained. Tikanga provides a framework 
through which Māori can actively engage with ethical issues and consider the effect 
research may have on their values or relationships. 
Na te tapu i puta mai te tikanga8
As a taonga, the protocols for dealing with human tissue, DNA and data in research 
should address both physical and spiritual components within the research 
process. Tikanga will ensure that the kawa (principles) outlined above are 
operationalised and the relationships between the researchers and the participants 
and communities are enhanced. There are three key stages within the research 
process where different tikanga could be applied to address cultural and ethical 
expectations. 
7 www.network.ac.nz.
8 Quote from cultural wananga held during Te Mata Ira project.
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Figure 7: Key Stages  
where Tikanga can  
be Applied
Te Tuku i te Taonga 
(sharing the gift)
Te Hau o te Taonga 
(the spirit of the gift)
Te Whakahoki i te Taonga 
(returning the gift)
 
I. Te Tuku i te Taonga (sharing of the gift)
Te Tuku i te Taonga refers to the point in time when a participant consents to their 
tissue/DNA/data being used as part of a research project. At a fundamental level 
the consent process establishes a relationship between the researchers and 
the participant. The process creates expectations of reciprocity, determines the 
parameters of the consent and also establishes levels of comfort and safety across 
both physical and spiritual dimensions.
Consent in the spiritual dimension relates to the process of wātea or whakawātea. 
In the research context it might involve the use of karakia by cultural experts 
(tohunga) to clear the way by removing anxieties that participants or communities 
might have about involvement in genomic research. This could happen at a project 
level (similar to the use of karakia to open a new building) or at the participant level 
(similar to the use of karakia by a hospital chaplain for a person before a significant 
operation). Addressing the spiritual dimensions of consent can also be supported 
by access to whānau support, as well as the use of Māori language and protocols 
during the recruitment and consent process.
Consent in the physical dimension builds on existing practices involving the use of 
patient information sheets and consent forms. It is important that these documents 
address the full range of important issues (e.g. use of tissue, use of data, conditions 
of consent, benefit-sharing, governance and future use arrangements).
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Example
Te Roopu Kaitiaki was established to support the participation of Māori within the 
LiLACS research project. The members of Te Roopu Kaitiaki were selected from tribes 
across Aotearoa with the brief of ensuring that Māori people and their language and 
culture would be acknowledged and valued throughout this research9. Te Roopu Kaitiaki 
supported the translation of information sheets, questionnaires, and consent forms 
into Māori and these were available for the LiLACS participants. The process although 
challenging was enriching for the research team as Kēpa10 observes; 
 
Translation by Te Roopu Kaitiaki o Nga Tikanga requires Māori language that is used 
by the oldest old Māori rather than fluent Māori language that combines English 
grammatical and phonological structures and Māori vocabulary. By creating a 
translation process that has never been used before and by being courageous enough 
to do so knowing full well that such a process may be disliked and rejected at any time, 
critical issues, distinctive interactions and innovations can be identified for study design 
and methodology in health and ageing research (p. 280).
II. Te Hau o te Taonga (the spirit of the gift)
Te Hau o te Taonga is a concept that refers to the expectations associated with 
the use of the tissue/DNA/data. Te Hau o te Taonga arises in the context of gifting 
land where the land is given for a specific purpose and the expectation that it 
will be returned if no longer required for the intended purpose. In the context of 
genomic research it supports the notion of tākoha and the responsibility to make 
decisions about the use of the taonga in a way which adheres to the parameters of 
consent, and respects the spirit in which the gift was given. Most decisions about 
the use of tissue/DNA/data occur after the point of consent so it is important to 
give consideration to the ways in which the kawa for genomic research will be 
operationalised (Henare, 2015).
The spiritual dimension of Te Hau o te Taonga relates most directly to principle  
‘Kia tau te wairua o te tangata’, the level of comfort that participants and 
communities have in the project. Identification of a kaitiaki (guardian) to support 
decision-making is one way to ensure the spirit of the gift is maintained as new 
possibilities emerge during the research project. Providing participants and 
9  Dyall, L., Skipper, T. K., Kēpa, M., Hayman, K., & Kerse, N. (2013). Navigation: Process of building 
relationships with kaumātua (Māori leaders). The New Zealand Medical Journal, 126(1368), 65. 
10  Kēpa, M., Kēpa, C. A., McPherson, B., Kameta, H., Kameta, F., Port, W., . . . Reynold, L. (2014). E 
kore e ngāro ngā kākano i ruia mai i Rangiātea: The language and culture from Rangiātea will 
never be lost in health and ageing research. AlterNative, 10(3), 276–287. 
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stakeholder communities with updates is a way to ensure they are informed about 
the progress of the project. This addresses the issue where participants feel that 
they lose control over time. 
The physical dimension of Te Hau o te Taonga relates most directly to the principle 
‘Kia pumau te mana o te tangata’, the level of control that participants and their 
communities have in the project. At a participant level it relates to the level of 
information and ability to withdraw consent. At a community level it relates to roles 
in the governance of the project and the ability to track and audit the use of tissue/
DNA/data. 
Examples
An Aboriginal Governance Committee for a research project looking at genetic 
contributions to rheumatic heart disease in Aboriginal communities established a 
Living Protocol to ensure that the cultural and spiritual significance of tissue was being 
recognised as the samples, DNA and data was shared between the research partners. 
The Living Protocol outlines ‘good manners’ in relation to the use of samples, DNA and 
data and provides statements that can be included in material transfer agreements and 
data use agreements. 
 
Tissue is considered by Aboriginal and Torres Strait Islanders to be sacred as it is  
a physical manifestation connecting collective stories of origin, identity and authority 
with aspirations for the future. A person’s uniqueness arises from their connection  
to country and kin. The rights and obligations created with community through the  
gift of tissue extends to every recipient [user] of that tissue.
The Neuro-Endocrine Tumour NETwork! project is establishing a collaboration 
of cancer clinicians and scientists to develop a national framework for managing 
neuroendocrine cancer that couples clinical practice with a translational research 
model to improve outcomes for patients with NET cancer. As a key aspect of the project 
is to collect NET cancer specimens from historic samples and from patients who 
are newly diagnosed with NET cancer. As the samples could be used for a number 
of different studies NETwork! has established a Governance Group and an Incidental 
Findings Committee to provide oversight in relation to the studies that get conducted 
and how information arising from them is used. Māori are represented on all of these 
committees including the research team.
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III. Te Whakahoki i te Taonga (return of the gift)
Te Whakahoki i te Taonga refers to the point in time when the genomic research 
project is complete and the responsibility for looking after the gift is returned to the 
community. This process is an expression of respect for relationship and provides 
an opportunity to report on all uses of the tissue/DNA/data and outcomes of the 
project. It also allows the research team to check in with the community about  
their level of comfort and satisfaction with the research process and openness  
to continuing a research relationship.
The spiritual dimension of Te Whakahoki i te Taonga relates to the communities 
level of comfort with the project at its conclusion, and assesses the project against 
the expectations of reciprocity anticipated at the beginning (Te Tuku i te Taonga). 
The metaphor of a ‘kawe mate’, where photos/taonga of a recently deceased 
person are taken to marae for whānau to grieve over, is associated with the 
acknowledgement and return of whānau members. The concept of a ‘kawe taonga’ 
emerged to recognise that often the actual tissue/DNA would not be able to be 
returned to participants and communities but a representation of those taonga in 
the form of reports or other information could be formally provided to the relevant 
communities.
The physical return of reports or provision of access to raw data is an important 
consideration for research teams to demonstrate respect for the community and 
providing opportunities for them to re-consent for future use and participation  
or consent to ‘exit’ the relationship supports the principle ‘kia pumau te mana  
o te tangata’ (level of control).
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Examples
A kaumatua from Ngāti Whātua spoke about the instructions given to the 28th Māori 
Battalion, a group of Māori soldiers that fought in World War 2. The elders realised  
that not all of them would return from the battles and were told that it was okay to  
bury the fallen on the other side of the world but that they should bring back a momento 
or something that belonged to the person so that the whānau could grieve for them. 
This in not unlike a kawe mate where a person is buried in a urupā in one region but  
a photo of them is taken to other regions so whānau from those places can also express 
their grief in a culturally appropriate manner. 
The kaumatua used this story as an analogy for the taking of tissue for research and 
suggested that while it may not be possible to return biological material to participants 
it was important that something came back. This might be the results of the study and 
he reiterated the importance of it being done in the right way. If discussions about the 
project had taking place with whānau or hapū then it should be in a formal manner  
on the marae. 
Me hoki rangatira mai mā te upoko, ehara mā te rārā. 
One should return through the front door,  
not the side door.
The Christchurch School of Medicine developed Guidelines for Disposal or Retention  
of Samples and Specimens for research involving Māori. The guidelines provide  
advice on what should be included in the information sheets and consent forms  
for the collection of samples including the option of disposal with karakia. 
For disposal of identified Māori samples (i.e samples taken from research participants 
who have requested to have ‘remaining samples disposed with appropriate karakia’ 
on the consent form) – at the end of the study the samples will be retained for the 
ceremony with appropriate karakia, then be disposed of immediately thereafter.
For any subsequent dissemination of Māori samples (e.g. to other labs participating  
in the study), those samples should also be identified with the appropriate sticker.  
The lab in receipt of the samples must be informed that any remaining sample material 
should be returned to the disseminating lab after testing is completed, or by a certain 
date, whichever comes first.
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Section 2
Te Mata Ira Framework  
for Genomic Research
When developing a genomic research project it is also important to prepare 
appropriately for engagement with whānau, hapū, Iwi, or Māori groups. Ideally, 
researchers should make use of different resources to familiarize themselves with 
Māori culture and ethics prior to engagement and that discussions should occur 
prior to the development of the research design. The kawa and tikanga outlined 
above as part of the cultural foundation provide some guidance around decision-
making in the context of genomic research. This section outlines the context and 
key issues11 that Māori have interests in discussing in relation to genomic research.
Te Ara Tika
Whakapapa Mana Tika Manaakitanga
Consultation
Kawa Governance Purpose Benefit
Research
Tikanga Consent Methods Communication
Transformation
Accountability Kaitiaki Translation Education
 
 
 
Figure 8: Te Mata Ira Framework for Genomic Research with Māori
Note: There are a range of resources that can provide context to Māori issues  
in research and genetics. These have been included in Appendix A.
11 These issues were identified through the HRC funded Te Mata Ira research project.
Te Mata Ira: Guidelines for Genomic Research with Māori20
Consultation Phase
Consultation12, 13 ensures that there has been a constructive critique of the proposed 
project and its potential impact on Māori, and also provides an opportunity for 
the community to consider the track record of the research team. Consultation 
assists with the development of clearly written information sheets, which specify 
that samples will only be used for the purpose for which they are taken14, provide 
a mechanism for reporting back results to appropriate parties15 and allow issues 
regarding the research scope and agenda16, 17 to be discussed. These are considered 
minimum requirements and should be reflected in the locality assessment and 
section F of the ethics application.18 
The consultation phase is the only opportunity for whānau, hapū, Iwi or Māori 
entities to influence the direction or design of the research project. This phase 
tends to engage with Māori as stakeholders in the project rather than as 
participants and will contribute to community consent or mandate for the research 
project. While discussions in the consultation phase are likely to extend to 
research and transformation the immediate issues for deliberation relate to kawa, 
governance, purpose, and benefit.
Consultation
Kawa Governance Purpose Benefit
a) Kawa
Kawa can provide principles to underpin the relationship that develops between 
researchers and the community. The principles should underpin the use of 
samples/DNA/data and provide guidance around limits of use in a research 
environment that promotes the sharing of samples and data, including the right 
to say no. Identifying appropriate kawa (principles) in research with human tissue 
emerged as a key issue for Iwi as tissue is a taonga, there is a tapu associated 
with its use in genomic research. This tapu and kawa extends to the data as a 
representation of the tissue. While some kawa has been identified in this document 
12 Ministry of Health (2006). 2.2.37, p. 9. 
13 Ministry of Health (2006). Appendix 8, Partnership 381–382, p. 79.  
14 Ministry of Health (2006). 2.2.33, p. 9.
15 Ministry of Health (2006). Appendix 8, Points to consider 386, p. 80.
16 Ministry of Health (2006). 2.0.23, p. 6. 
17 Ministry of Health (2006). 2.7.82, p. 17. 
18 Ministry of Health (2009). National Application Form for Ethical Approval of a Research Project 
v1, Section F, ‘Cultural and social responsibility’. 
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it is important to understand that each whānau, hapū and/or Iwi may wish to apply 
their own kawa to the project. 
The types of questions to expect from Māori entities relevant to kawa include:
• What type of relationship are you looking for?
• Can Iwi modify the focus of the research?
• What principles inform the research project?
• What principles are used to make decisions about the use of samples  
and data?
• How will Māori rights and interests in intellectual property be recognised?
• How can we ensure our tikanga is upheld?
b) Governance
While kawa helps identify the principles that inform the use of samples, DNA and 
data, the issue of governance refers to the people and processes that control 
access and use. Participation within governance processes is the primary means 
of protecting interests and limiting unauthorised use. Governance in the context 
of genomic research occurs at multiple levels and there are a range of decision-
making bodies where Māori could participate, including project governance groups, 
community advisory boards, and institutional management committees. Māori will 
want to participate in any committee or decision-making process about access to 
DNA samples, genomic data, whakapapa information, or clinical data so they can 
be involved in setting conditions for access and use, and reviewing progress.
The types of questions to expect from Māori entities relevant to governance include:
• What governance arrangements are in place? 
• For the project? For the biobank? (for samples consented for future use)
• How can we be involved in the governance of samples, research information 
and genomic data? e.g. Use for different purposes
• Who holds the research information and genomic data, for how long  
and who can access it?
• What rights do donors have to control use? 
 – Through dynamic consent or re-consent 
 – Will donors receive communication about each use?
• Who will own the research once it is completed?
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c) Purpose
A key discussion with Māori stakeholders in the consultation phase of a research 
project relates to purpose. The purpose of the research, its intended outcomes,  
and the make up of the research team will all contribute to whether the project  
is supported. Projects contributing to Māori health priorities are likely to be 
favoured. It is also important to differentiate and be clear about the purpose of 
the initial project, potential purposes of future projects, and the purpose of any 
biobanking activity associated with the study. 
The types of questions to expect from Māori entities relevant to purpose include:
• He aha te putake o te rangahau? What is the purpose of the research?
• Who is funding the research? 
• Why is the research important for our community and for Māori generally? 
• What impact will the research have?
• What outcomes are researchers aiming to achieve?
• Who is involved in the research team? 
 – Are there any Iwi/Māori researchers?
 – What experience does the team have working with Māori communities? 
d) Benefit
The benefits of the project should outweigh the risks to Māori and there should  
be direct benefits for the Māori participants and their communities. Equity and 
justice are ethical principles underpinning the importance of benefit-sharing.  
Research will also have a range of outcomes and part of the ethical deliberation  
is to consider the nature of the outcomes (risk versus benefit, short versus 
long term benefit) and their relative distribution (researchers, participants, 
communities, society). Researchers will legitimately benefit from being involved 
in research but consideration should be given to how participants and their 
communities might also benefit from participation. This might include capacity 
building and pathways for benefit sharing should commercialisation  
opportunities arise.
The types of questions to expect from Māori entities relevant to benefit include:
• What benefits will come from participating in the research?
• How will we benefit? 
• What opportunities are there for our people to be involved or employed? 
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Research Phase
The research phase is more directly concerned with how Māori participants and 
their samples/DNA/data will be treated. The key issues for discussion in this phase 
include tikanga, consent, methods and communication.
Research
Tikanga Consent Methods Communication
 
e) Tikanga
Tikanga (cultural protocols) should inform the research practices within the project 
to ensure the cultural safety of participants and their communities. For example, 
tikanga can be applied in the context of engagement with communities, the 
collection and disposal of samples/DNA/data, and the future use of samples/DNA/
data. Tikanga might also be applied to issues of data security and inform material 
transfer or data use agreements.
The types of questions to expect from Māori entities relevant to tikanga include:
• What happens to the samples that are collected? 
• Can we track where the samples are and what they are being used for?
• What other whānau, hapū and Iwi samples are part of the same project? 
• Can we visit the research facility?
• How long are samples kept?
• What is the process of discarding samples? 
• What tikanga could be applied and how?
f) Consent
The scope and specificity of the consent is a key consideration from a Māori 
perspective. There is a preference that participants consent for every use  
but discussions in the consultation phase may allow for specific project use, 
disease-specific use, or broad unspecified use. A distinction should be made 
between consent for specific research projects, and consent for future use 
(biobanking). There is an expectation that there will be specific consents for 
genetic or genomic analyses, access to clinical records, and use for possible 
commercialisation. Consideration should also be given to whether specific 
consents are required for the return of results (research, individual, incidental 
findings), anonymisation of biospecimens, and putting genomic information on open 
data sharing platforms. Broader, less specific consents may be acceptable when 
Te Mata Ira: Guidelines for Genomic Research with Māori24
balanced by stronger governance arrangements and/or dynamic re-consenting 
models that support a focus on participation in projects that support Māori health 
priorities. Similarly, the timing of consent could be staggered to allow people  
to consent to clinical trials or sub-studies in the first instance, and to consent  
for future use at the end of the initial study.
The types of questions to expect from Māori entities relevant to consent include:
• What choices do participants get to make?
• What are the parameters of consent?
• Would you like participants to consent for unspecified future use?
• Do you want access to clinical information? 
g) Methods
The usefulness of the research will depend on the quality of the design, analysis 
and interpretation of the project. The involvement of Māori researchers and/
or community experts is advisable for determining sampling protocols and the 
framing and interpretation of results. For projects that are looking at genomic 
comparisons between Māori and other groups, the technical design and analytical 
frameworks for these projects should be reviewed by external Māori researchers 
with expertise in genomics.
The types of questions to expect from Māori entities relevant to consent include:
• Has the project been reviewed by Māori experts? 
• How will Māori be involved in the analysis and interpretation of data?
h) Communication
Communication was identified as a key issue for Iwi and should take place within 
all spheres of biobank activities and engagement with individuals through to 
communities. There can be multiple pathways for communication with both active 
and passive channels (for example; letters, newsletters and websites). Returning 
results should be communicated in an appropriate manner (to participants/
whānau and/or general practitioners) with due regard for issues of privacy and 
confidentiality. A process for the return of incidental findings that are significant 
or clinically actionable should be defined and agreed upon. Access to genetic 
counselling should also be facilitated and issues for biological relatives considered 
(by clearly communicating any level of risk). This is especially relevant for  
mono-genic conditions (like E-Caederin Stomach cancer gene; or ALD gene)  
but it will be important to develop ways to improve general genetic literacy  
of the community to deal with information about genetic risks for multi-genic 
conditions (e.g. Diabetes, gout, CVD).
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The types of questions to expect from Māori entities relevant to communication 
include:
• How will updates and results be reported back?
 – When?
 – Who?
• How do Iwi access the results? 
• Can individual participants access their results?
• How will you contact participants about incidental or clinically actionable 
findings?
• Who will be the primary contact for the project? And biobank? 
Transformation Phase
The transformation phase is the period post-project where the impact of the 
research project can be realised. Improved outcomes for Māori health motivates 
the engagement of whānau, hapū and/or Iwi in genomic research projects and 
there should be active mechanisms to deliver on this goal. Key issues to discuss 
with Māori entities as part of the planning for the transformation phase include 
accountability, kaitaiki, translation, and education.
Transformation
Accountability Kaitiaki Translation Education
i) Accountability
Accountability in this context relates to the relationship between the research team 
and communities that supported the research project. Expectations for ongoing 
feedback and communication with participants and Māori communities are key 
ways in which research teams can demonstrate accountability. Samples and 
data should be used with due regard to the donors consent and for studies which 
contribute to Māori health priorities. Communities should be acknowledged when 
their data is included in secondary studies (with their approval) and they should 
receive study results from any secondary use of their samples or data. Research 
organisations are accountable to the participants and their communities for their 
decisions around future use of samples and facilitating benefit sharing mechanisms 
for commercialisation opportunities. Re-contact options that facilitate re-consent 
for secondary use may be one avenue to demonstrate this responsibility.
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The types of questions to expect from Māori entities relevant to accountability 
include:
• How will researchers be accountable to the community?
• How are decisions made around which organisations can access the samples?
• Will there be any restrictions around access or use?
• How will donors be informed about use of their samples?
 – Use in projects
 – Results of projects
• Is there a mechanism for benefit sharing?
• If there is a problem, who can we talk to about the research and/or the 
researchers? 
j) Kaitiaki
Kaitiakitanga is a form of guardianship with responsibility to look after specific 
resources. In the context of genomic research it relates to the use of samples,  
DNA and data (genome data, clinical data, and information about whakapapa).  
It is important to clarify who holds the role of kaitiaki within the research team  
and the community, and that they are aware of the responsibilities of that position 
to maintain ‘te hau o te taonga’. Although communities should retain veto rights 
over how samples and data are used, and data sharing (for secondary use and open 
platforms) should only occur with the express permission of the participants and 
mandated representatives from the community, there are still a wide range  
of situations where decisions will be necessary.
The types of questions to expect from Māori entities relevant to kaitiaki include:
• Ma wai e tiaki? Who will look out for our interests?
• Who will be responsible for the samples, information and data? 
• What options are there for storing the samples?
 – Is there a Māori or indigenous biobank?
• How long can samples be used before renewing consent?
k) Translation
Knowledge translation informs resource allocation and can support service 
development. These are key outcomes for Māori communities from research. 
The challenge for genomic researchers is to articulate how genomic research 
translates to improved health outcomes across the spectrum of public health and 
personalised medicine. The relevance of the research results should be shared 
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with participants and their communities, and clinically actionable results should  
be shared with clinicians and service providers using an ethically defensible plan19.
The types of questions to expect from Māori entities relevant to translation include:
• What are the steps to developing a clinically relevant outcome?
 – Diagnostic tools
 – Education and health promotion
 – Pharmaceutical interventions 
• How does genomic research translate to health interventions? 
 – Health service delivery
 – Clinical decision making
 – Type and dosage of medication 
 – Public health messages
• When a genetic basis for disease is discovered, how do whānau talk  
about this? 
 – What support can be accessed?
l) Education
Māori recognise that genomic research will become an important part of the 
health system in the future. Improving levels of genetic literacy amongst Māori 
communities and levels of cultural literacy amongst science communities is 
necessary to ensure beneficial outcomes for Māori health. A component of this  
is to better understand how genomic research translates to health interventions 
and what the steps are to developing clinically relevant outcomes. Similarly,  
when a genetic basis for disease is discovered, how do whānau talk about this  
and what support is available to assist with this process?
The types of questions to expect from Māori entities relevant to education include:
• What support is there for educating the community about genomic research 
and biobanking?
• Where can we access information to help us make decisions?
 – Whether to engage
 – What to do with the results
• What information and advice can we access to support our whānau?
19 Where research may discover or generate information of potential importance to the future 
health of participants, or their blood relatives, researchers must prepare and follow an ethically 
defensible plan to disclose or withhold that information.
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Section 3 
Guidance Tables
The Guidance Tables have been developed to provide specific advice on three 
areas that researchers and communities have frequently queried; determining 
appropriate engagement, using appropriate methodologies, and identifying 
pathways for benefit sharing.
Appropriate Engagement
An important part of conducting genomic research with Māori communities is 
engaging with the right people. Māori have expressed an interest in being involved 
in research conversations at the earliest stage possible, however the nature 
of this engagement will vary from case to case. This may require a number of 
conversations to get the right level of input into the project and a robust process 
of engagement will involve Māori with expertise in research (preferably genomic 
research), Māori with an understanding of cultural protocols, and Māori with 
background in the context which the project focuses on (i.e. cardio vascular 
disease, diabetes).
Engagement always has a purpose and can be functional in terms of support for 
a project, or strategic in terms of developing a mutually beneficial relationship. 
Engagement in the research context is usually based around consultation, consent 
(individuals and collectives), and support. Genomic projects focused at different 
scales within the Māori population will need to determine the appropriate whānau, 
hapū, Iwi or Māori entities to engage with. The table below provides some examples 
of what level of consultation, consent and support are appropriate for different 
types of genomic research.
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Study 
Focus
Example Level of 
Consultation
Level of 
Consent
Level of 
Support
Tangata: 
General 
Population
With/without 
Māori cohort
New Zealand Wide Gout 
Study, 
Growing up in New 
Zealand Study,
Neuro-endocrine Tumour 
Study (NETwork!), LiLACS
Institutional and 
Representative
Individual 
consent
 
 
Māori 
Institutional 
support 
Iwi and agency 
endorsement 
Whānau support 
for individual 
consent
 
Whānau: Family 
Population
Familial Gastric Cancer, 
Adrenoleukodystrophy
Whānau and Iwi Whānau consent 
for project 
Individual 
consent to 
participate
Marae, hapū 
and/or Iwi 
endorsement 
for project 
Whānau support 
for individual 
consent
Marae/Hapū/
Iwi: Community 
Population
Rakaipaaka Health and 
Ancestry Study, Genetics 
of Gout in Ngāti Porou
Iwi and 
Institutional
Marae, hapū or 
Iwi consent for 
project
Individual 
consent to 
participate
 
Iwi endorsement 
for project
Māori 
institutional 
support
Whānau support 
for individual 
consent
 
Pan-Iwi: Ethnic 
Population
Hauora Manawa: Heart 
Health Community Heart 
Study, 
Te Wai o Rona Diabetes 
Prevention Strategy
Multiple Iwi 
and hapū, 
Institutional and 
Representative
Multiple Iwi 
consents for 
project
Individual 
consent to 
participate
 
Whānau support 
for individual 
consent
Māori 
Institutional 
endorsement
Table 2: Appropriate Engagement
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Appropriate Methods
The research design and statistical analyses chosen for the study have an effect 
on what the study is able to detect and how that information can be interpreted. 
There are a number of examples of genetic and genomic research studies that 
have caused harm to indigenous communities. The ‘Warrior Gene’ is a recent 
example which mistakenly linked social characteristics to an ethnic population 
based on weak genetic data that was poorly analysed and interpreted. The harm 
felt by pockets of the Māori community resulted in greater levels of mistrust 
amongst the Māori community towards genetic researchers. Researchers have an 
ethical responsibility to do no harm and need to consider this not only in relation 
to participants providing samples but also in terms of how their interpretation of 
data creates stories in/about/for the community. Therefore, appropriate analytical 
methods are needed, along with careful interpretations and communication  
of results. 
Table 3 describes the different analytical methods for different types of study 
design. In general, less complex analytical methods are required for single gene 
(i.e., Mendelian) conditions that typically occur with whānau/whānui-level research. 
Gene effects for such conditions are typically very large, and thus easily handled 
using standard analytical methods. For more complex conditions, such as polygenic 
disease, much larger populations are needed. The suite of analytical methods need 
to more judiciously applied, beginning with designing a study with sufficient size to 
adequately test underpinning biological hypotheses. A variety of tools are available 
for this. 
Data analyses also need to be considered carefully. More advanced analytical 
methods are constantly being developed, including methods that determine overall 
trait heritability (i.e., the total sum of all genes contributing to variation among 
study participants) in addition to the contribution of individual genes. Methods for 
analyses of Iwi- and pan-Iwi-level association studies should include estimation of 
both admixture and relatedness. A variety of methods are available which account 
for these phenomena, including methods that exclude candidate polymorphisms 
from simultaneous estimation of relatedness and association which can weaken 
power to detect true associations. The need to use ‘best practice’ analyses is 
obvious, however what this actually consists of frequently changes. We therefore 
advise researchers to constantly evaluate literature describing and comparing 
analytical methods, and to be able to justify analytical methods used. Moreover, 
data should be analysed using multiple methods: similar results from different 
methods is usually indicative of an underpinning biological basis to the observed 
data set (i.e., real gene effects). 
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In the recent past, disease heritabilities were not often calculated in candidate 
gene-based and genome-wide association studies of complex traits. Our view is 
that they should be: if a trait is not heritable then specific gene-trait associations 
are likely false positives, therefore of limited diagnostic or clinical relevance. 
Moreover, heritability estimates provide for a clearer representation of the total 
role of genes in disease, which can in turn dispel myths about the conditions. For 
example, currently in Aotearoa, New Zealand there is general acceptance of the 
role of genes in gout incidence, yet less acceptance of the role of genes in obesity 
and comorbidities such as Type 2 diabetes mellitus, despite similar estimated 
heritabilities in these conditions reported in overseas studies. Heritabilities can be 
estimated using relatedness estimated from genome-wide marker panels. Some 
caveats here are (a) more distant relatedness is less precisely estimated using 
such panels, thus some caution is needed when interpreting estimates of genetic 
variance and heritability, and (b) admixture can create errors in marker-based 
relationship estimation, thus needs to be accounted for when estimating kinship. 
Te Mata Ira: Guidelines for Genomic Research with Māori32
Study Focus Examples Designs Statistical Analysis Interpretation(s)
Tangata: General 
Populations 
With or without Māori cohort 
NZ-wide gout case-control 
studies
Genome-wide association studies using 
case control or unstructured populations 
(for continuously distributed traits) (disease 
presence/absence):
candidate gene-based SNPs, or
genome-wide genotyping with SNP chips, 
or exome capture or whole genome 
sequencing.
Designs should be appropriately powered 
(i.e., with adequate sample sizes) and 
estimate power of detection using 
appropriate methods. Designs should 
maximise power of detection of small effect 
SNPs.
Power to detect loci needs to be considered: 
how much of the genetic variance is 
explained by (non) detected variants?  
In other words, small studies will likely 
not detect most of the disease-associated 
variants? Of those variants that are detected 
in these studies, have they been replicated? 
Data preparation: imputation of missing data points using 
appropriate reference populations. Ensure appropriate 
filtering on sequencing-derived data, especially if inferring 
rare variants.
Methods for identifying genes associated with trait  
variation should:
• Test candidate SNPs as fixed effects
• Control for population admixture 
• Control for co-ancestry via genomic relationship matrix 
estimation excluding candidate SNP in mixed linear 
model analyses. This is not necessary in some  
Bayesian methods.
• Accommodate testing of multiple polymorphisms
• Be computationally efficient
• Estimate trait heritability
• Provide unbiased estimates of SNP effects, 
• Be applicable to multiple (correlated) traits, and
• Incorporate prior information where available  
(e.g., Bayesian methods)
Results should also be compared with results from other 
studies, and ideally be included in meta-analyses that 
typically involve combining the data from multiple studies.
Actual effects of individual disease 
associated DNA sequence variants are 
usually very small, and only contribute small 
amounts to risk.
Having some of the ‘disease gene(s)’  
does not mean those with the gene(s) will 
get the disease – rather, the likelihood of 
developing the disease is increased, i.e., 
that relative risk is increased, but usually 
not markedly for complex traits unless have 
many of the causative genes (and often with 
a family history).
Whānau: Family Population Familial Gastric Cancer, 
Adrenoleukodystrophy.
Family-based designs are generally 
targeted at Mendelian traits and/or  
descendants of carriers of de novo 
mutations. Optimal design depends upon 
mode of gene action and penetrance 
Generally involves either identity-by-
descent or homozygosity mapping with 
either candidate genes, whole exomes or 
whole genome resequence. Populations 
need to be sufficiently large, particularly 
for detecting incompletely penetrant and/
or recessive genes, which usually requires 
multiple siblings with recent common 
ancestors, as well as good clinical records.
Various options for identifying disease-linked 
polymorphisms:
• Simple linear regression for continuous phenotypes,  
chi-square or Fisher’s exact test for qualitative 
phenotypes. 
• homozygosity mapping for recessive Mendelian traits
• Genome-wide IBD estimation for missing data and  
linked loci
• Independent validation of associations, particularly with 
affected whānui
• Imputation for genome-wide data using a relevant 
reference genome 
For those carrying the disease-causing 
genes there is a high likelihood of  
condition/disease. 
Hapū/Iwi: Community 
Population 
Rakaipaaka Health and 
Ancestry Study, Ngati Porou 
Genetics of Gout in Ngati 
Porou 
As for general population. Rare variants 
need to be validated in specific whānau 
where the variant is segregating. 
As above, for general populations. Especially important 
that relatedness be incorporated in analytical methods 
used to estimate genetic effects. Admixture also needs 
to be taken into account, particularly if using linear mixed 
models. Genome wide estimation methods likely to 
particularly useful here, taking advantage of the spectrum 
of relatedness that occur within the populations.
As for general population. Additional 
consideration given to family history when 
interpreting results and estimating risk. 
Marker-based estimates of heritability will 
also provide a framework for assessing 
genetic vs non-genetic effects for specific 
conditions. These provide estimates of the 
genetic and environmental contributions.
Pan-Iwi: Ethnic population NZ-wide gout study in Māori As for general population. Rare variants 
need to be validated in specific whānau 
where the variant is segregating.
As above for hapū/Iwi. Especially important to account 
for admixture, owing to multiple ethnicities. Genome wide 
estimation also likely to have value here.
 As for hapū/Iwi
Table 3: Appropriate Methods
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Study Focus Examples Designs Statistical Analysis Interpretation(s)
Tangata: General 
Populations 
With or without Māori cohort 
NZ-wide gout case-control 
studies
Genome-wide association studies using 
case control or unstructured populations 
(for continuously distributed traits) (disease 
presence/absence):
candidate gene-based SNPs, or
genome-wide genotyping with SNP chips, 
or exome capture or whole genome 
sequencing.
Designs should be appropriately powered 
(i.e., with adequate sample sizes) and 
estimate power of detection using 
appropriate methods. Designs should 
maximise power of detection of small effect 
SNPs.
Power to detect loci needs to be considered: 
how much of the genetic variance is 
explained by (non) detected variants?  
In other words, small studies will likely 
not detect most of the disease-associated 
variants? Of those variants that are detected 
in these studies, have they been replicated? 
Data preparation: imputation of missing data points using 
appropriate reference populations. Ensure appropriate 
filtering on sequencing-derived data, especially if inferring 
rare variants.
Methods for identifying genes associated with trait  
variation should:
• Test candidate SNPs as fixed effects
• Control for population admixture 
• Control for co-ancestry via genomic relationship matrix 
estimation excluding candidate SNP in mixed linear 
model analyses. This is not necessary in some  
Bayesian methods.
• Accommodate testing of multiple polymorphisms
• Be computationally efficient
• Estimate trait heritability
• Provide unbiased estimates of SNP effects, 
• Be applicable to multiple (correlated) traits, and
• Incorporate prior information where available  
(e.g., Bayesian methods)
Results should also be compared with results from other 
studies, and ideally be included in meta-analyses that 
typically involve combining the data from multiple studies.
Actual effects of individual disease 
associated DNA sequence variants are 
usually very small, and only contribute small 
amounts to risk.
Having some of the ‘disease gene(s)’  
does not mean those with the gene(s) will 
get the disease – rather, the likelihood of 
developing the disease is increased, i.e., 
that relative risk is increased, but usually 
not markedly for complex traits unless have 
many of the causative genes (and often with 
a family history).
Whānau: Family Population Familial Gastric Cancer, 
Adrenoleukodystrophy.
Family-based designs are generally 
targeted at Mendelian traits and/or  
descendants of carriers of de novo 
mutations. Optimal design depends upon 
mode of gene action and penetrance 
Generally involves either identity-by-
descent or homozygosity mapping with 
either candidate genes, whole exomes or 
whole genome resequence. Populations 
need to be sufficiently large, particularly 
for detecting incompletely penetrant and/
or recessive genes, which usually requires 
multiple siblings with recent common 
ancestors, as well as good clinical records.
Various options for identifying disease-linked 
polymorphisms:
• Simple linear regression for continuous phenotypes,  
chi-square or Fisher’s exact test for qualitative 
phenotypes. 
• homozygosity mapping for recessive Mendelian traits
• Genome-wide IBD estimation for missing data and  
linked loci
• Independent validation of associations, particularly with 
affected whānui
• Imputation for genome-wide data using a relevant 
reference genome 
For those carrying the disease-causing 
genes there is a high likelihood of  
condition/disease. 
Hapū/Iwi: Community 
Population 
Rakaipaaka Health and 
Ancestry Study, Ngati Porou 
Genetics of Gout in Ngati 
Porou 
As for general population. Rare variants 
need to be validated in specific whānau 
where the variant is segregating. 
As above, for general populations. Especially important 
that relatedness be incorporated in analytical methods 
used to estimate genetic effects. Admixture also needs 
to be taken into account, particularly if using linear mixed 
models. Genome wide estimation methods likely to 
particularly useful here, taking advantage of the spectrum 
of relatedness that occur within the populations.
As for general population. Additional 
consideration given to family history when 
interpreting results and estimating risk. 
Marker-based estimates of heritability will 
also provide a framework for assessing 
genetic vs non-genetic effects for specific 
conditions. These provide estimates of the 
genetic and environmental contributions.
Pan-Iwi: Ethnic population NZ-wide gout study in Māori As for general population. Rare variants 
need to be validated in specific whānau 
where the variant is segregating.
As above for hapū/Iwi. Especially important to account 
for admixture, owing to multiple ethnicities. Genome wide 
estimation also likely to have value here.
 As for hapū/Iwi
Table 3: Appropriate Methods
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When communicating results care is also needed to avoid unwarranted 
reinforcement of negative stereotypes which typically occurs with the use  
of negative terms such as ‘deficits’, ‘elevated disease risk’ etc, as these can  
be considered to imply a genetic inferiority. Such notions are akin to Darwinian 
selection, which had previously provided early British colonists with a basis for 
discriminating against indigenous population in countries such as in New Zealand.
Benefit Sharing
Equity and justice are ethical principles underpinning the importance of benefit-
sharing. Research will also have a range of outcomes and part of the ethical 
deliberation is to consider the nature of the outcomes (risk versus benefit, short 
versus long term) and their relative distribution (researchers, participants, 
communities, society). Researchers will legitimately benefit from being involved 
in research but consideration should be given to how participants and their 
communities might also benefit from participation through research,  
education and translational activities.
Research Education Translation
Participant/community 
access to additional health 
resources 
• tests
• screening
• expertise
• genetic counselling
Feedback to participants to 
• provide information about the 
contribution of genetic & environmental 
factors (i.e. consumption and exercise)  
to health incidence
• increase levels of understanding about 
genetic conditions
• information about whakapapa
Improvements to health 
service delivery
• access
• screening
• clinical decision making
• personalised medicines
Capacity building
• internships
• scholarships
• research positions
• research workshops
• relationships/
partnerships with 
research providers
Community workshops and hui to
• provide information about the relevant 
disease
• provide information about the 
contribution of genetic & environmental 
factors to health incidence
• increase levels of understanding about 
genetic conditions
• make informed consent processes  
more robust
Improvements to health 
literacy in community
• Supports conscious 
decision-making around 
genetic conditions 
(genetic literacy)
• Activating healthy 
communities (health 
promotion)
Information for community
• Research reports
• Baseline data for future 
Iwi studies/interventions
• Shared intellectual 
property
Develop project resources (print/website)
• Genetic literacy
• Health promotion
Support Information 
Sovereignty
• Māori stewardship of 
data and information
• Māori research capacity
 
Table 4: Benefits for Communities
35Section 3: Guidance Tables
Benefits to researchers
• Status and reputation
• Qualifications (Masters and PhD theses)
• Personal advancement – particularly enhanced publication records
• Increasing networks
• Broadened life experiences and skills
 
Benefits to participants
• Access to interventions
• Opportunity to share experiences
• Koha
• Acknowledgement in publications
• Copies of reports
 
Benefits to participant communities
• Research capacity – research skills, understanding research processes
• Access to interventions
• Collection and protection of existing intellectual property
• Knowledge advancement
• Copies of reports
• Sharing of new intellectual property
 
Benefit to Māori
• Community development, for example health promoting events
• Researcher development for example qualifications and research experience
• Knowledge advancement, for example research outputs, hui (meetings/
seminars) and wānanga (workshops/teaching sessions)
• Development of mātauranga Māori
 
Benefit to society
• Knowledge advancement for example research outputs, hui and wānanga
• Inclusiveness and diversity within the research system
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Section 4 
Special Ethical  
Considerations
Incidental Findings
Tissue, DNA and data stored within biorepositories often ends up as a sample 
within a research project that produces an incidental finding. Incidental findings 
are results unrelated to the primary focus of the study but which may be significant 
for the individual’s health. The nature of genomic research, which analyses a vast 
number of genes across the genome, will frequently produce incidental findings. 
The challenge is to determine whether the finding is statistically significant, 
clinically significant, and/or clinically actionable. Māori communities expect to  
be notified of any clinically significant or actionable findings. It is the responsibility 
of the research team to develop an ethically defensible plan20 of how they will 
address incidental findings that emerge through their study.
Data Rights and Interests
Internationally, human tissue samples and associated genomic data from  
Māori and Polynesian sources are becoming an increasingly valuable resource.  
Opportunities for benefit-sharing with Māori communities is connected to an  
acknowledgement that they have an inherent right to derive benefits from the  
use of their taonga. These rights have been articulated in the Mataatua Declaration 
and the UN Declaration on the Rights of Indigenous Peoples and also underpin 
recent discussions on Indigenous Data Sovereignty. 
Māori have expressed a belief that they have rights to tissue and the genomic 
data associated with it, as well as an interest in the outcomes of research and 
applications of their data. There is also a belief that genomic data, like their clinical 
data, was personal information. Its use in the public domain as part of supporting 
research is to improve health outcomes for their community. While many recognise 
that the pathway to the delivery of benefit often involves commercial entities there 
are concerns about their personal information becoming corporatised through 
research activities. There is an expectation that those who contribute to research 
should receive direct benefits over and above those delivered to the general public. 
20 National Health and Medical Research Council (NHMRC). National statement on ethical conduct 
in human research. Canberra: NHMRC, Australian Government; 2007. Available from:  
https://www.nhmrc.gov.au/guidelines-publications/e72 [Verified 21 May 2015]. 
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Figure 9:  
Information Flow Personal Information
Public Information
Private Information
Corporate Information
Data Linkage
Data is a representation of tissue and genetic information is a highly valuable 
strategic asset to Māori. There is some concern about the linking of datasets 
across different domains and there is an expectation of Māori involvement in 
governance over access to and the linking of data. The kawa developed for genomic 
research can also be applied to data governance, addressing ‘wairua’ through 
regular communication, ‘mana’ by providing direct benefits, and ‘mauri’ through 
transparent processes that enhance trust in the integrity of the system. 
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Glossary of Māori Terms
Disclaimer: Many of the descriptions used in this glossary are specific 
interpretations for the purposes of this document and do not denote  
the fullness of meaning normally associated with the word or term.
Awe māpara  Ink used for traditional tattoo
Hapū  Kinship group
Hui Meetings, seminars
Iwi Tribe
Kai Food
Kaitiaki Guardian/advocate
Kanohi ki te kanohi Face to face
Karakia Prayer, incantation
Kaumātua Elder
Kaupapa Topic, purpose
Kawa  Principles
Kuia Female elder
Māhaki Respectful conduct 
Mana Justice and equity, power and authority, control
Mana akiaki Empowerment 
Mana tangata Autonomous individual
Mana whakahaere Shared power and control of outcomes and dissemination
Mana whenua Regional authority, customary title over land
Manaakitanga To look after, care for
Mātaawaka Māori living within the area not related to local iwi
Mātauranga Traditional knowledge 
Noa Unrestricted 
Tāmoko Traditional tattoo
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Tangata whenua People of the land
Taonga Precious, resources
Tapu Restricted 
Te Ao Māori Māori world 
Te Mata Ira Faces of the genes
Tika Right, correct
Tikanga Protocols and practices
Wai Water
Waiata Song, singing
Wānanga Workshops, teaching sessions
Whakanoa To free from restriction, 
Whakapapa Genealogy, relationships 
Whakatauki Proverb
Whakawātea To remove tapu
Whānau Family, extended family, kin network
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Glossary of Science Terms
Term Definition
Admixture Presence of intermarriage/interbreeding between 
genetically distinct groups. For example high levels 
of intermarriage between Māori and pākeha indicates 
extensive admixture in contemporary Māori.
Biomedical research Research that is undertaken in a Biomedical context or 
with intended biomedical outcomes.
Candidate gene Genes thought (hypothesised) to be responsible for 
causing a specific condition or characteristic (phenotype).
Cell lines Usually refers to genetically identical cells that are 
perpetually cultured in vitro. Used for experimental 
purposes. 
Co-ancestry Shared (or common) ancestry. Populations with relatively 
few ancestors have higher levels of co-ancestry. 
Darwinian selection Natural selection, where individuals who have particular 
characteristics have an advantage relative to the rest of 
the population, thus contributing disproportionately to the 
next generation. An example could be individuals who are 
resistant to a particular deadly pathogen.
De novo mutations Changes in DNA sequence that occur for the first time 
in either male or female gametes (i.e sperm or egg), and 
thus appear in the offspring but not previous generations.
DNA sequencing Processes and technologies for ascertaining DNA 
sequence of organisms. Most widely used technology 
platform is Illumina-based, which generate large 
amounts of short read sequences.
Epigenetics Changes arising from alterations in gene expression 
levels that are caused by reversible chemical 
modification of DNA, but not changes to the DNA 
sequence passed on from parents to offspring. 
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Gene Various definitions: 1) a hereditary unit; 2) a region  
of DNA that codes for a specific form of a protein;  
3) a region of DNA that contains a specific sequence  
that is transcribed into RNA and influences biology  
of the organism.
Genetic research Investigations of the influence of inherited genetic 
variation on specific characteristics. Genetic research  
in a health context usually involves correlating either 
DNA sequence variants with health outcomes.
Genetic variance Variation in inherited DNA sequence between individuals 
within or between populations. Some of this variation is 
referred to as the genetic variance (i.e. heritability) that 
explains some of the variance in phenotype between 
individuals within a specified population.
Genome The entire DNA sequence of an individual, including it’s 
physical arrangement.
Genomics Refers to the study (including technologies) of the 
entire genome of an organism, including the physical 
arrangement of the genome.
Genome Wide 
Association Study
An experimental procedure where millions of variations 
in DNA sequence spread across the entire genome of a 
population of individuals are correlated with variation in 
a physical characteristic or phenotype (e.g., disease) to 
identify genes responsible for variation in phenotype.
Genome-wide 
estimation
Estimation of genetic variation from a genome-wide set 
of genetic variants. Used to estimate heritability. 
Genotype Various meanings. As a verb, it refers to the process  
of determining DNA sequence at a loci or set of loci.  
As a noun, ‘genotype’ refers to the DNA sequence  
at a specified locus for an individual.
Genotyping Process of determining the DNA sequence of a specific 
individual at predetermined sites (loci) in the genome.
Heritability The proportion of observed variation in an observed 
characteristic that is attributable to inherited genetic 
variation. For example most (80%) of the variation in 
human height is due to inherited genetic variants,  
thus height is described as being ‘highly heritable’.
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Homozygosity Refers to regions of DNA where an individual’s sequence 
inherited from the father is the same as the region 
inherited from the mother. Higher rates of homozygosity 
in the genome of an individual are consistent with  
in-breeding. 
Imputation Refers to a mathematical process used to calculate 
missing genotypic information of individuals. Used to 
increase data, typically in genome-wide association 
studies. 
Loci Plural of the term ‘locus’, which referees to a specific 
regions of genome. Usually to a functional region,  
such as a a region encoding an expressed gene,  
or some other biological significance.
Mendelian A characteristic or a gene that behaves according 
Mendel’s laws of inheritance. In medical contexts,  
refers to diseases that are caused by a single genetic 
change (similar to monogenic) that can be traced  
from generation to generation within a family. 
Metabolomics Refers to the study of the entire set of metabolites  
within an organism or tissue.
Mono-genic Where genetic variation in a characteristic is due to a 
single gene (‘mono’ = one). Often used in reference to 
Mendelian diseases that are caused by a single gene. 
Multi-genic Where genetic variation in a characteristic is the 
combined result of multiple genes. This is the case for 
common diseases such as diabetes, cancer, psychiatric 
diseases, and for human characteristics such as height 
and weight. 
Next Generation 
sequencing (NGS)
DNA sequencing technologies that are typically high 
throughput but read only short fragments of DNA.
Polygenic Same as multi-genic: ‘Poly’ meaning ‘many’. Usually 
refers to heritable conditions and characteristics that 
involve many genes – ranging from tens to thousands. 
Polymorphisms Literally means ‘many forms’. In a genetics context, 
refers to differences in DNA sequence.
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Pharmacogenomics Refers to the research and practice of targeting 
particular drug therapies to an individual based on their 
genotype at particular genes. For example, individuals 
who metabolise a drug faster may require a higher dose 
of that drug, or individuals could be genetically prone  
to an adverse event for a particular drug, which wouldn’t 
be used for that individual.
Phenotype Physical appearance or characteristics of an individual.
Proteomics Refers to the study of the entire set of proteins within 
an organism or tissue. Proteins are translated from 
expressed genes.
SNP’s Single Nucleotide Polymorphisms – A single letter 
change in DNA code usually measured directly via 
DNA sequencing methods, or via ‘chip’ microarray 
technologies.
Tissue Bank Physical location of a collection of tissues used for 
medical and other research. Can be termed a Biobank.
Transcriptomics Refers to the study of the entire set of expressed genes 
within an organism or tissue. Usually involves indirectly 
sequencing RNA.
Variants Usually refers to differences in DNA sequences.
Whole Genome 
Sequence
The entire DNA sequence of an individual. Usually 
determined for experimental or research purposes,  
or to develop information resources that can inform 
genetic analyses in biomedical research.
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Appendix A:  
Relevant Resources
Critique(s) of genetics-based research in Indigenous populations –  
http://www.conversations.canterbury.ac.nz/documents/FINAL%20NGAPAEPAPER.doc 
Māori protocols – http://www.katoa.net.nz/kaupapa-Māori/Māori-protocols
National Congress of American Indians Genetics Resource Centre –  
http://www.ncai.org/policy-research-center/initiatives/projects/genetics-resource-center
Research consultation with Māori (Otago University policies) – 
http://www.otago.ac.nz/research/Māoriconsultation/ 
Te Aroturuki – http://www.dabhand.co.nz/tap/index.html (draft)
Genetics Education Websites:
• http://www.genetics.edu.au 
• http://www.geneticseducation.nhs.uk 
• http://learn.genetics.utah.edu/ 
• https://unlockinglifescode.org/ 
• https://www.theguardian.com/science/2013/jun/08/genome-sequenced 
Youtube videos:
• Genomics – https://www.youtube.com/watch?v=mmgIClg0Y1k 
• Genomics in healthcare – https://www.youtube.com/watch?v=KiQgrK3tge8 
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